HANCOCK WHITNEY CORP - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 137 filers reported holding PDL BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
HANCOCK WHITNEY CORP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2023$0128,3960.0%0.00%
Q2 2023$0128,396
-24.4%
0.00%
Q1 2023$0169,801
-8.1%
0.00%
Q4 2022$0184,7690.0%0.00%
Q3 2022$0184,7690.0%0.00%
Q2 2022$0184,7690.0%0.00%
Q1 2022$0184,7690.0%0.00%
Q4 2021$0184,7690.0%0.00%
Q3 2021$0184,7690.0%0.00%
Q2 2021$0
-100.0%
184,769
-1.6%
0.00%
-100.0%
Q4 2020$464,000
+0.9%
187,757
+28.6%
0.02%
-11.8%
Q3 2020$460,000
+10.3%
145,964
+1.8%
0.02%
+6.2%
Q2 2020$417,000
-23.8%
143,377
-26.1%
0.02%
-23.8%
Q1 2020$547,000
+40.3%
193,896
+61.3%
0.02%
+61.5%
Q4 2019$390,000
-16.7%
120,184
-44.5%
0.01%
-13.3%
Q3 2019$468,000
-41.6%
216,627
-15.1%
0.02%
-42.3%
Q2 2019$801,000
-14.7%
255,153
+1.1%
0.03%
-13.3%
Q1 2019$939,000
+38.7%
252,479
+8.1%
0.03%
+30.4%
Q4 2018$677,000
-2.6%
233,584
-11.6%
0.02%
+15.0%
Q3 2018$695,000
+1.5%
264,099
-9.8%
0.02%
-37.5%
Q2 2018$685,000292,8080.03%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders